Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza

Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza

Background The pharmacokinetics and appropriate dose regimens of favipiravir are unknown in hospitalized influenza patients; such data are also needed to determine dosage selection for favipiravir trials in COVID-19. Methods In this dose-escalating study, favipiravir pharmacokinetics and tolerabili...

Podrobná bibliografie
Hlavní autoři:	Wang, Y, Zhong, W, Salam, A, Tarning, J, Zhan, Q, Huang, J-A, Weng, H, Bai, C, Ren, Y, Yamada, K, Wang, D, Guo, Q, Fang, Q, Tsutomu, S, Zou, X, Li, H, Gillesen, A, Castle, L, Chen, C, Zhen, J, Lu, B, Duan, J, Guo, L, Jiang, J, Cao, R, Fan, G, Li, J, Hayden, FG, Wang, C, Horby, P, Cao, B
Médium:	Journal article
Jazyk:	English
Vydáno:	Elsevier 2020

Podobné jednotky

Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza
Autor: Yeming Wang, a další
Vydáno: (2020-12-01)

Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection
Autor: Wang, Y, a další
Vydáno: (2019)

Understanding the clinical utility of favipiravir (T-705) in coronavirus disease of 2019: a review
Autor: Kritika Srinivasan, a další
Vydáno: (2021-12-01)

Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus
Autor: Hideki Tani, a další
Vydáno: (2016-02-01)

Favipiravir (T-705) inhibits Junín virus infection and reduces mortality in a guinea pig model of Argentine hemorrhagic fever.
Autor: Brian B Gowen, a další
Vydáno: (2013-01-01)

Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and Non-obese volunteers.
Autor: Chairat, K, a další
Vydáno: (2016)

Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever.
Autor: Lisa Oestereich, a další
Vydáno: (2014-05-01)

Broad spectrum antiviral activity of favipiravir (T-705): protection from highly lethal inhalational Rift Valley Fever.
Autor: Amy L Caroline, a další
Vydáno: (2014-04-01)

A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza.
Autor: Le, Q, a další
Vydáno: (2010)

Effective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic Fever.
Autor: Michelle Mendenhall, a další
Vydáno: (2011-10-01)

Favipiravir (T-705) Protects IFNAR<sup>−/−</sup> Mice against Lethal Zika Virus Infection in a Sex-Dependent Manner
Autor: Keesha Matz, a další
Vydáno: (2021-05-01)

The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase.
Autor: Zhinan Jin, a další
Vydáno: (2013-01-01)

Preimplantation Genetic Testing for Aneuploidy Could Not Improve Cumulative Live Birth Rate Among 705 Couples with Unexplained Recurrent Implantation Failure
Autor: Liu Y, a další
Vydáno: (2024-02-01)

Comparison of oseltamivir and oseltamivir carboxylate concentrations in venous plasma, venous blood, and capillary blood in healthy volunteers.
Autor: Instiaty, I, a další
Vydáno: (2013)

Tool condition monitoring using ae signal in turning of assab-705 steel
Autor: Choudhury, I.A., a další
Vydáno: (2010)

Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus
Autor: Mariana Baz, a další
Vydáno: (2018-11-01)

Pharmacokinetics of high-dose oseltamivir in healthy volunteers.
Autor: Wattanagoon, Y, a další
Vydáno: (2009)

Characteristics of HBV infection in 705 HIV-infected patients under lamivudine-based antiretroviral treatment from three regions in China
Autor: Su M, a další
Vydáno: (2018-10-01)

An Investigation into Turning of ASSAB-705 Steel Using Multiple Sensors
Autor: Bhuiyan, M.S.H., a další
Vydáno: (2016)

CETE91 tool condition monitoring using ae signal in turning of ASSAB-705 steel
Autor: Choudhury, I.A., a další
Vydáno: (2010)

Oseltamivir resistance during treatment of influenza A (H5N1) infection.
Autor: Jong, d, a další
Vydáno: (2005)

Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics.
Autor: Seo, S, a další
Vydáno: (2013)

Comparative outcomes of adults hospitalized with seasonal influenza A or B virus infection: application of the 7-category ordinal scale
Autor: Wang, Y, a další
Vydáno: (2019)

T-705-Derived Prodrugs Show High Antiviral Efficacies against a Broad Range of Influenza A Viruses with Synergistic Effects When Combined with Oseltamivir
Autor: Benedikt Ganter, a další
Vydáno: (2023-06-01)

Combination effects of peramivir and favipiravir against oseltamivir-resistant 2009 pandemic influenza A(H1N1) infection in mice.
Autor: Sehee Park, a další
Vydáno: (2014-01-01)

Effects of dexamethasone coadministered with oseltamivir on the pharmacokinetics of oseltamivir in healthy volunteers
Autor: Jang K, a další
Vydáno: (2017-03-01)

Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: Opportunistic retrospective study of medical charts in China
Autor: Yu, H, a další
Vydáno: (2010)

Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China.
Autor: Yu, H, a další
Vydáno: (2010)

Inhibitory activity of selenium nanoparticles functionalized with oseltamivir on H1N1 influenza virus
Autor: Li Y, a další
Vydáno: (2017-08-01)

Measurement report: quantifying source contribution of fossil fuels and biomass-burning black carbon aerosol in the southeastern margin of the Tibetan Plateau
Autor: H. Liu, a další
Vydáno: (2021-01-01)

Combination therapy of nitazoxanide with oseltamivir compared with oseltamivir in hospitalized patients with seasonal influenza
Autor: Parvaiz A Koul, a další
Vydáno: (2024-01-01)

Impacts of biogenic and anthropogenic emissions on summertime ozone formation in the Guanzhong Basin, China
Autor: N. Li, a další
Vydáno: (2018-05-01)

Improvement of outcomes of an escalated high‐dose methotrexate-based regimen for patients with newly diagnosed primary central nervous system lymphoma: a real-world cohort study
Autor: Li Q, a další
Vydáno: (2021-08-01)

Oseltamivir and influenza-related complications in children: a retrospective cohort in primary care
Autor: Lee, J, a další
Vydáno: (2020)

Pharmacokinetics of orally administered oseltamivir in healthy obese and nonobese Thai subjects.
Autor: Jittamala, P, a další
Vydáno: (2014)

Pharmacokinetics of orally administered oseltamivir in healthy obese and nonobese thai subjects
Autor: Jittamala, P, a další
Vydáno: (2014)

Analytical Study on Inherent Properties of a Unidirectional Vibrating Steel Strip Partially Immersed in Fluid
Autor: J. Li, a další
Vydáno: (2013-01-01)

A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza
Autor: Mai, L, a další
Vydáno: (2010)

Plasma concentrations of oseltamivir and oseltamivir carboxylate in critically ill children on extracorporeal membrane oxygenation support.
Autor: Enno D Wildschut, a další
Vydáno: (2010-01-01)

Expression and Clinical Value of miR-185 and miR-424 in Patients with Acute Ischemic Stroke
Autor: Guo C, a další
Vydáno: (2022-01-01)